Head of Gene Therapy Unit
Novartis
As Head of the Gene Therapy Unit at Novartis, I lead a multidisciplinary team driving the preclinical development of innovative gene therapy programs. In this role and more than a decade of experience in R&D, I specialize in advancing neuromuscular disease therapeutics through strategic planning, risk mitigation, and cross-functional collaboration. My approach prioritizes scientific excellence and alignment with company goals, fostering impactful partnerships with internal stakeholders and external collaborators.
See also: https://www.novartis.com
Connect with us on social media